Literature DB >> 12676851

Contraindications to use of metformin. Age and creatinine clearance need to be taken into consideration.

Andrew T Elder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12676851      PMCID： PMC1125663          DOI： 10.1136/bmj.326.7392.762/a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  Contraindications to the use of metformin.

Authors:  G C Jones; J P Macklin; W D Alexander
Journal:  BMJ       Date:  2003-01-04

2.  Prediction of creatinine clearance from serum creatinine.

Authors:  D W Cockcroft; M H Gault
Journal:  Nephron       Date:  1976       Impact factor: 2.847

3.  Improving the care of elderly diabetic patients: the final report of the St Vincent Joint Task Force for Diabetes.

Authors:  T J Hendra; A J Sinclair
Journal:  Age Ageing       Date:  1997-01       Impact factor: 10.668

4.  Oral hypoglycaemic agents in 118 diabetic pregnancies.

Authors:  E Hellmuth; P Damm; L Mølsted-Pedersen
Journal:  Diabet Med       Date:  2000-07       Impact factor: 4.359

5.  Type 2 diabetes in the elderly: an assessment of metformin (metformin in the elderly).

Authors:  J D Lalau; A Vermersch; L Hary; M Andrejak; F Isnard; J Quichaud
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1990-08

6.  Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome.

Authors:  C J Glueck; Ping Wang; Suichi Kobayashi; Harvey Phillips; Luann Sieve-Smith
Journal:  Fertil Steril       Date:  2002-03       Impact factor: 7.329

7.  Nephrotoxicity of contrast media in high-risk patients with renal insufficiency: comparison of low- and high-osmolar contrast agents.

Authors:  G Deray; M F Bellin; H Boulechfar; B Baumelou; F Koskas; A Baumelou; J Grellet; C Jacobs
Journal:  Am J Nephrol       Date:  1991       Impact factor: 3.754

8.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.